Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension

References

• Abuelgasim E, Shah S, Abuelgasim B, et al. Clinical overview of diabetes mellitus as a risk factor for cardiovascular death. Rev Cardiovasc Med. 2021;22(2):301–314. doi:10.31083/j.rcm2202038
   PubMed Web of Science ®Google Scholar
• Bailes BK. Diabetes mellitus and its chronic complications. Aorn J. 2002;76(2):266–276, 278–282; quiz 283–266. doi:10.1016/s0001-2092(06)61065-x
   Google Scholar
• Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018;61(6):1249–1260. doi:10.1007/s00125-018-4557-7
   PubMed Web of Science ®Google Scholar
• Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013–2018. JAMA. 2021;326(24):2498–2506. doi:10.1001/jama.2021.22208
   PubMed Web of Science ®Google Scholar
• Mancia G, Scopelliti F, Grassi G. Hypertension and the heart. Semin Cardiothorac Vasc Anesth. 2006;10(3):198–202. doi:10.1177/1089253206291315
   PubMedGoogle Scholar
• Lu Q, Zhang Y, Geng T, et al. Association of lifestyle factors and antihypertensive medication use with risk of all-cause and cause-specific mortality among adults with hypertension in China. JAMA Netw Open. 2022;5(2):e2146118. doi:10.1001/jamanetworkopen.2021.46118
   PubMed Web of Science ®Google Scholar
• Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE million persons project). Lancet. 2017;390(10112):2549–2558. doi:10.1016/s0140-6736(17)32478-9
   PubMed Web of Science ®Google Scholar
• Jin Z, Pan Z, Wang Z, et al. CYSLTR1 rs320995 (T927C) and GSDMB rs7216389 (G1199A) gene polymorphisms in asthma and allergic rhinitis: a proof-of-concept study. J Asthma Allergy. 2022;15:1105–1113. doi:10.2147/jaa.S371120
   PubMed Web of Science ®Google Scholar
• Wang Z, Kong L, Zhang H, et al. Tumor necrosis factor alpha −308G/A gene polymorphisms combined with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio predicts the efficacy and safety of anti-TNF-α therapy in patients with ankylosing spondylitis, rheumatoid arthritis, and psoriasis arthritis. Front Pharmacol. 2021;12:811719. doi:10.3389/fphar.2021.811719
   PubMed Web of Science ®Google Scholar
• Gils A, Declerck PJ. Plasminogen activator inhibitor-1. Curr Med Chem. 2004;11(17):2323–2334. doi:10.2174/0929867043364595
   PubMed Web of Science ®Google Scholar
• Altalhi R, Pechlivani N, Ajjan RA. PAI-1 in diabetes: pathophysiology and role as a therapeutic target. Int J Mol Sci. 2021;22(6):6. doi:10.3390/ijms22063170
   Web of Science ®Google Scholar
• Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers and the risk of incident hypertension. Hypertension. 2007;49(3):432–438. doi:10.1161/01.HYP.0000256956.61872.aa
   PubMed Web of Science ®Google Scholar
• Zhao L, Bracken MB, Dewan AT, Chen S. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis. Mol Hum Reprod. 2013;19(3):136–143. doi:10.1093/molehr/gas056
   PubMed Web of Science ®Google Scholar
• Du J, Lan J, Yang H, et al. Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) gene polymorphism with susceptibility to prostate cancer: an updated meta-analysis. World J Surg Oncol. 2022;20(1):354. doi:10.1186/s12957-022-02812-x
   PubMed Web of Science ®Google Scholar
• Zhang J, Shi H, Xue M, et al. An insertion/deletion polymorphism in the interleukin-1A 3’untranslated region confers risk for gastric cancer. Cancer Biomark. 2016;16(3):359–365. doi:10.3233/cbm-160574
   PubMed Web of Science ®Google Scholar
• Zhang Q, Jin Y, Li X, et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review. Vasa. 2020;49(2):141–146. doi:10.1024/0301-1526/a000839
   PubMed Web of Science ®Google Scholar
• Huang X, Li Y, Huang Z, Wang C, Xu Z. Pai-1 gene variants and COC use are associated with stroke risk: a case-control study in the Han Chinese women. J Mol Neurosci. 2014;54(4):803–810. doi:10.1007/s12031-014-0418-0
   PubMed Web of Science ®Google Scholar
• Gao WF, Guo YB, Bai Y, Ding XY, Yan YJ, Wu ZQ. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population. Int Urol Nephrol. 2016;48(9):1483–1489. doi:10.1007/s11255-016-1333-9
   PubMed Web of Science ®Google Scholar
• Wang S, Cao Q, Wang X, et al. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis. PLoS One. 2013;8(2):e56797. doi:10.1371/journal.pone.0056797
   PubMed Web of Science ®Google Scholar
• Li W, Mao S, Wu L, Shi W, Zhang J, Wang Z. Association between the PAI-1 4G/5G gene polymorphism and the risk of systemic lupus erythematosus/lupus nephritis. Crit Rev Eukaryot Gene Expr. 2019;29(1):85–94. doi:10.1615/CritRevEukaryotGeneExpr.2019025311
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(sici)1096-9136(199807)15:7<539::Aid-dia668>3.0.Co;2-s
   PubMed Web of Science ®Google Scholar
• Liu LS. 中国高血压防治指南2010 [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615. Chinese.
   PubMedGoogle Scholar
• Navarro E, Serrano-Heras G, Castaño MJ, Solera J. Real-time PCR detection chemistry. Clin Chim Acta. 2015;439:231–250. doi:10.1016/j.cca.2014.10.017
   PubMed Web of Science ®Google Scholar
• Miri S, Sheikhha MH, Dastgheib SA, Shaker SA, Neamatzadeh H. Association of ACE I/D and PAI-1 4G/5G polymorphisms with susceptibility to type 2 diabetes mellitus. J Diabetes Metab Disord. 2021;20(2):1191–1197. doi:10.1007/s40200-021-00839-7
   PubMed Web of Science ®Google Scholar
• Xu K, Liu X, Yang F, et al. PAI-1-675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study. PLoS One. 2013;8(11):e79150. doi:10.1371/journal.pone.0079150
   PubMed Web of Science ®Google Scholar
• Jacobs A, Schutte AE, Ricci C, Pieters M. Plasminogen activator inhibitor-1 activity and the 4G/5G polymorphism are prospectively associated with blood pressure and hypertension status. J Hypertens. 2019;37(12):2361–2370. doi:10.1097/hjh.0000000000002204
   PubMed Web of Science ®Google Scholar
• Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women. Chin Med J). 2012;125(7):1249–1253.
   PubMed Web of Science ®Google Scholar
• Emamian M, Hasanian SM, Tayefi M, et al. Association of hematocrit with blood pressure and hypertension. J Clin Lab Anal. 2017;31(6):6. doi:10.1002/jcla.22124
   Web of Science ®Google Scholar
• Song J, Wei N, Zhao Y, Jiang Y, Wu X, Gao H. Elevated glycosylated hemoglobin levels and their interactive effects on hypertension risk in nondiabetic Chinese population: a cross-sectional survey. BMC Cardiovasc Disord. 2020;20(1):218. doi:10.1186/s12872-020-01501-5
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Sato M, Shirai K, Suzuki K, Tatara K. White blood cell count as a risk factor for hypertension; a study of Japanese male office workers. J Hypertens. 2002;20(5):851–857. doi:10.1097/00004872-200205000-00018
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhou C, Liu M, et al. Neutrophil counts and the risk of first stroke in general hypertensive adults. Hypertens Res. 2021;44(7):830–839. doi:10.1038/s41440-021-00625-1
   PubMed Web of Science ®Google Scholar
• Woo SJ, Ahn SJ, Ahn J, Park KH, Lee K. Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects. Invest Ophthalmol Vis Sci. 2011;52(10):7697–7703. doi:10.1167/iovs.11-7784
   PubMed Web of Science ®Google Scholar
• Boncoraglio GB, Bodini A, Brambilla C, Carriero MR, Ciusani E, Parati EA. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke. Cerebrovasc Dis. 2006;22(2–3):191–195. doi:10.1159/000093604
   PubMed Web of Science ®Google Scholar
• Kovács KR, Bajkó Z, Szekeres CC, et al. Elevated LDL-C combined with hypertension worsens subclinical vascular impairment and cognitive function. J Am Soc Hypertens. 2014;8(8):550–560. doi:10.1016/j.jash.2014.04.007
   PubMed Web of Science ®Google Scholar
• Luo SH, Yang DZ, Wei XY, et al. 成年1型糖尿病患者胰岛素抵抗与血脂紊乱的关系 [Association of insulin resistance with dyslipidemia in adults with type 1 diabetes]. Zhonghua Yi Xue Za Zhi. 2019;99(34):2665–2669. Chinese. doi:10.3760/cma.j.issn.0376-2491.2019.34.006
   PubMedGoogle Scholar